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ABSTRACT 
 
BACKGROUND AND OBJECTIVES: 
Neonatal seizures are clinically significant because very few are 
idiopathic. Further investigation leading to prompt diagnosis of the 
underlying condition as well as associated biochemical abnormality is 
important for specific treatment. Recognition of hypomagnesemia and 
hypocalcaemia is important for therapeutic implications. 
Objectives: To evaluate the prevalence of hypomagnesemia in  
neonatal seizures,  To evaluate the prevalence of hypocalcaemia and rate 
of association of hypomagnesemia with hypocalcemia. 
METHODOLOGY: 
Our study is an observational study included 150 neonates  based 
on inclusion and exclusion criteria defined , presenting during the period 
of one year from July 2014 to July 2015.Then relevant investigations 
including biochemical parameters were done and etiology of neonatal 
seizures and their associated biochemical abnormalities were diagnosed.  
  
RESULTS: 
The prevalence of hypomagnesemia among 150 selected neonates 
with seizures is 4.6% and prevalence of hypocalcemia is 31.3%. 
Prevalence of Combined hypocalcemia with hypomagnesemia 4% and 
isolated hypomagnesemia is 0.6%. Association of hypomagnesemia with 
hypocalcemia is 83% which is statistically significant. 
CONCLUSION: 
Hypomagnesemia as isolated abnormality for cause of seizure, or 
as associated abnormality in underlying etiology is rare. But 83% of 
hypomagnesemia is associated with hypocalcemia implying the 
interrelation in pathophysiology. So in documented hypocalcemia there is 
a need to estimate the levels of magnesium to find the associated 
hypomagnesemia because treatment of hypomagnesemia is definitive 
with magnesium salts.  
KEY WORDS: 
Hypomagnesemia, Hypocalcemia, Neonatal seizures, 
Hypomagnesemia with Hypocalcemia, Metabolic abnormalities. 
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INTRODUCTION 
 
Neonatal seizures are sometimes the only clinical
1
 sign of the 
presence of CNS disorders in the neonate. Thus it may indicate the 
presence of a potentially treatable cause and should promote an 
immediate search for the cause and for starting appropriate therapy.                     
It is essential to determine the etiology of seizure at the earliest 
because it gives an opportunity to treat the seizure actively and promptly 
and avoid preventable morbidity, mortality and sequelae associated with 
it.  
In our modern sophisticated medicine era, though the mortality due 
to seizures has decreased over years, the prevalence of long-term 
neurodevelopment adverse outcome
2
 has largely remained unchanged. 
Inadequate and improper management of seizures `could be the reason for 
this. 
Even with established etiology for neonatal seizures there is 
significant contribution to the seizure activity by the underlying 
biochemical abnormalities. So early recognition of associated 
biochemical abnormalities and appropriate treatment is essential for  
better outcome. 
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Among the metabolic causes of seizures good prognosis
3
 are with 
hypoglycaemia, hypocalcemia and hypomagnesemia. But most of 
hypocalcemic seizures are accompanied by hypomagnesemia, but 
Magnesium levels are rarely investigated in resource restricted hospitals 
and Magnesium has neuroprotective role. 
Interest in the physiology and chemistry
4
 of the mineral 
magnesium has gradually increased over a period of time. Mg is involved 
in the activation of Na/K ATPase pump of cell membranes hence it 
maintains the electrical potential across the membrane, and Mg is also 
needed for enzymes that play a role in cell membrane stability and nerve 
conduction, and hypomagnesaemia leads to nerve and muscle excitability.  
It has been suggested that low serum Mg has occasionally been 
associated with significant effects on the central nervous system 
especially in epilepsy. A positive correlation of the hypomagnesemia with 
the severity of epilepsy was also found and more severe the epilepsy, the 
lower was the plasma Mg. 
Magnesium acts on the nervous system by reducing the release of 
acetylcholine at the level of neuromuscular junction
5
 by antagonising 
calcium ions it reduces the excitability of nerves. Thus it acts as an 
anticonvulsant, and also reverses the cerebral vasospasm. 
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In our NICU, seizures are the most common cause for admission 
and it occupies a significant proportion of adverse neurological outcome 
in babies discharged. So in order to know the prevalence of 
hypomagnesemia in neonatal seizures in our setup I have taken this study. 
Hypocalcemia in a significant proportion of seizures is associated 
with hypomagnesemia and treatment with only calcium will worsen the 
seizure activity. But when magnesium is administered the minimum 
mineral requirement are met and this itself results in increased calcium 
retention. So on administering magnesium both hypocalcemia and 
hypomagnesemia is corrected. Thus how often hypomagnesemia 
associated with hypocalcaemia has to be studied. 
In this study I have concentrated on the associated metabolic 
abnormality in an established cause of neonatal seizures particularly on 
hypomagnesemia and hypocalcemic-hypomagnesemia 
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AIMS AND OBJECTIVES 
 
PRIMARY OBJECTIVE: 
1. To evaluate the prevalence of hypomagnesemia in all neonates 
admitted with seizures by analyzing the serum magnesium levels  
SECONDARY OBJECTIVE: 
1. To evaluate the prevalence of hypocalcaemia and rate of 
association of hypomagnesemia with hypocalcemia within the 
study group 
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REVIEW OF LITERATURE 
 
Magnesium (Mg) is third common intracellular cation
5
 and fourth 
common cation in the body. It is mainly found in muscles, other soft 
tissues, bones and erythrocytes. 
As early as 1944, a correlation between magnesium, tetany, and 
petitmal seizures was reported
6
. Since then numerous studies have been 
made in the deficiency of magnesium by many investigators. Beck 
observed in 1952 that a deficiency of magnesium might well produce 
effects similar to hypophysectomy. Martin, Meke and Wertman
7
 did a 
very comprehensive study on the clinical influence of magnesium 
metabolism, and again noted that in the state of epilepsy, there was a 
deficiency of serum magnesium. Numerous investigators have noted a 
form of  tetany and occasional petit mal in this syndrome where a low 
magnesium intake was noted. Clinical observations in man
8-10
and 
experimental investigations in animals
17
 have shown that magnesium 
(Mg) depletion causes a marked irritability of the nervous system, 
eventually resulting in epileptic seizures.  
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The possibility of seizures due to hypomagnesemia  provoked the 
interest to study the metabolism of Mg in the seizures , and a trend of low 
magnesium was found.
11-15
 In successive studies, Hirschfelder and 
Haury
16-19 
found a lowering of Mg and a rise of potassium in the blood of 
epileptic patients, leading to a definite increase in the K/Mg ratio, 
proportional to the severity of the disease. Concerning the metabolism of 
magnesium in the cerebrospinal fluid, Cohen,
20
 McCance and 
Watchorn
21
, and Greenberg andAird
22
 found in epilepsy the same range 
of magnesium levels as in other nervous diseases. Hirschfelder and 
Haury
23
 found low concentrations of Mg in the cerebrospinal fluid of 
epileptic patients, though the levels were higher than in the blood 
Epidemiology  
The National Neonatal Perinatal Database, which collected data 
from 18 tertiary care units across the country, has reported an incidence 
of 10.3 per 1000 live-births. The incidence was found to increase with 
decreasing gestation and birth weight - for example, preterm infants had 
almost twice the incidence when compared to term neonates
24
 (20.8 vs. 
8.4 per 1000 live-births) while very low birth weight infants had more 
than 4-fold higher incidence (36.1 per 1000 live-births). 
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DEFINITION OF SEIZURES  
A seizure is defined clinically as a paroxysmal alteration in 
neurologic function, i.e. motor, behaviour and/or autonomic function. 
This definition includes
25
:  
1. Epileptic seizures: phenomena associated with corresponding 
EEG seizure activity e.g. clonic seizures  
2. Non-epileptic seizures: clinical seizures without corresponding 
EEG correlate e.g. subtle and generalized tonic seizures  
3. EEG seizures: abnormal EEG activity with no clinical 
correlation.  
CHARACTERISTICS IN NEWBORN SEIZURES 
A seizure is the most frequent sign of neurologic dysfunction in the 
neonate. Since seizures may be the only sign of a central nervous system 
disorder, their recognition is important
26
.  
The neonatal period, unquestionably is the most hazardous period 
of life, never again in life an individual is confronted with more dramatic 
changes than in transition from dependent intrauterine existence to 
independent post natal life. The new born brain responds in the form of 
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convulsion even for a minor insult, because of the immaturity of the 
nervous system. 
The pattern of newborn seizures varies from the of seizure in adults 
due to the immaturity in anticonvulsant network in the developing brain. 
The precise reason must relate to developmental state of nervous 
system in the prenatal period. The most common neuroanatomical 
processes occurring in that period are organizational events. This process 
must be highly significant in providing cortical organization to propagate 
and sustain a generalized seizure. Such a degree of cortical organization 
is apparently not present in human neonates
27
.  
 The presentation of a newborn with seizure represents a true 
emergency
28 
and frequently indicates significant neurological dysfunction 
or damage to the immature nervous system
29
. The neonate is at particular 
risk for development of seizures because of metabolic, anoxic, structural 
and infectious causes, although no cause can be identified in one fourth of 
cases. Clinical presentation of seizure, etiology, management and 
diagnosis of seizure differ markedly to convulsions occurring in older 
children
30. 
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CLASSIFICATION OF NEONATAL SEIZURES 
The international classification of epileptic seizures does not apply 
to newborn seizures
31
 because neonates are unstable to sustain organized 
discharges and do not manifest generalized tonic clonic seizures.  
Any abnormal, repetitive and stereotypic behaviour in neonates 
should be evaluated as possible seizure
32
.  
Volpe in 1989 gave 
8-10 
very simple and effective classification i.e., 
he sub classified seizures into four types: subtle, clonic, tonic and 
myoclonic
33
. 
This classification is in use recently. 
Hill and Volpe in year 1994 classified neonatal seizures into following 
types: 
1) Subtle 
2) Tonic 
        a. Generalized  
        b. Focal 
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3) Clonic 
       a. Multifocal 
       b. Focal 
4) Myoclonic 
       a. Focal 
       b. Multifocal 
c. Generalized. 
SUBTLE SEIZURES: 
The most common form  of neonatal seizures is subtle seizures. 
Available information from studies using EEG simultaneously with slow 
recording or direct observation suggests that: 
1. It is more common in premature infants. 
2. Many clinical phenomenon’s which are subtle  in full term infants 
are not always associated with abnormal EEG discharge. Eye 
opening, ocular movements, peculiar extremity movements (e.g., 
resembling boxing or hooking movement), mouth movements 
and apnea have been documented in association with EEG 
seizure activity, usually in temporal leads. 
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In study of Mizrahi and Kellaway
34
, 22 infants of which 19 (85%) 
were more than 36 weeks of gestation exhibited paroxysm of ocular 
movements such as eye blinking, oral buccal lingual movements, 
pedalling or stepping movements or rotator arm movements with an 
inconsistent association with EEG seizure activity.  
The data appear to indicate that much caution should be used in 
attributing an epileptic origin to many subtle clinical phenomenon, 
particularly in full-term infant and particularly if these phenomenon are 
the only manifestation of seizure in the infant. Although apnea has been 
demonstrated as a seizure manifestation in the premature newborn 
35
, vast 
majority are non-epileptic in origin. In 14 of the 21 infants studied by 
Watanabe et al
36
 the infants exhibited other subtle phenomenon during 
the apneic seizure e.g., staring, mouth movements. Apnea as a seizure 
with EEG activity is less likely to be associated with bradycardia than in 
non-convulsive apnea. 
CLONIC SEIZURES: 
Clonic seizures (Fig 1) which involves clonic movements in the 
newborn are characterized by rhythmic and usually slow activity. It can 
be focal or multifocal.  
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Infants commonly are not clearly conscious during or after the 
focal seizures and the neuropathology is often focal in nature e.g., 
cerebral infarction. However, it is important to recognize that focal clonic 
seizures may occur with metabolic encephalopathies  in the newborn.  
 
Fig 1: Tonic and Clonic phase of neonatal seizure 
TONIC SEIZURES:  
Tonic seizures are clinical episodes most common of which are 
unassociated with time-synchronized EEG discharges. Two types of tonic 
seizures must be differentiated - focal and generalized. Generalised tonic 
seizures are more common in newborn than focal one. 
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Focal tonic (Fig 2) seizures are characterised by sustained / 
asymmetric posturing of the limb, neck or trunk. In contrast to 
generalized tonic seizures, focal are consistently associated with EEG 
activity.  
GTS is characterized mostly  by tonic extension of upper and lower 
limbs. Approximately 85% of such clinical seizures are not accompanied 
by electrical seizure activity. 
 
Fig 2: Tonic seizures in new born 
MYOCLONIC SEIZURES:  
Myoclonic seizures are clinical episodes that as a group are most 
commonly unassociated with time synchronized EEG discharges. 
Myoclonic movements are distinguished from clonic by its characteristic  
more rapid speed of the myoclonic jerks, and it has predilection for flexor 
group of muscles .  
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Three categories should be distinguished  
(1) Focal  
(2) Multifocal  
(3) Generalized.  
SEIZURES VERSUS JITTERINESS / NON-EPILEPTIC 
MOVEMENTS: 
Jitteriness, although not a type of seizure, is a movement disorder 
that is often confused with seizure. It is classically a disorder of the 
newborn. Jitteriness is characterized by movements primarily of 
tremulousness. Distinguishing jitteriness from seizure (Table:1) can be 
done at the bedside, by comparing the following five points. 
Table-1: Difference between jitteriness and seizures in neonates 
S. No Clinical features   
1. Abnormality of gaze or eye movement 0 + 
2. Movements, exquisitely stimulus sensitive + 0 
3. Predominant movement Tremor Clonic jerking 
4. Movements cease with passive flexion + 0 
5. Autonomic changes 0 + 
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The most consistently defined causes of jitteriness are HIE, 
hypocalcemia, hypoglycemia and drug withdrawal. It should be noted 
that the distinguishing clinical features described above are useful in the 
clinical distinction of episodic movements other than jitteriness that 
might be confused with an epileptic seizure. 
Of particular importance is the increase of non-epileptic 
movements with sensory stimulation, their suppression with gentle 
restraint and their lack of accompaniment by metabolic changes. Finally 
it is important to recognize that newborns exhibit normal motor activity 
that could be mistaken for seizure. Awareness of such normal activity 
should allow ready distinction from seizure at bedside
37
. 
ACTIVITIES THAT ARE COMMONLY MISTAKEN FOR 
SEIZURES: 
Awake or Drowsy: 
• Roving, sometimes dysconjugate eye movements. 
• Sucking, puckering movements not associated by ocular 
phenomenon. 
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Sleep: 
• Fragmentary myoclonic jerk 
• Isolated, generalized myoclonic jerk as infant wakes from sleep. 
Of all the seizures in neonates, subtle seizure is the commonest in 
majority of the studies. In a study of neonatal seizures by Brunquell 
Philip J et al
38
 subtle seizures were the commonest seen in 51% (27 out of 
53), followed by focal clonic seen in 42%(22 out of53), multifocal clonic 
seen in 30%(16 out of 53) and generalized tonic in 23%(12 out of 53).  
In a study by Lakra Mahaveer et al 
39
subtle seizures were the 
commonest seen in 52 out of 93 cases (56.98%) followed by focal clonic 
seen in 21 out of 93 cases(23%) and multifocal clonic seen in 18 out of 
93 cases (19.35%). 
The etiology of neonatal seizures due to a combination of 
abnormalities is more common in sick neonates
40
. Although asphyxia is a 
cause of neonatal includes hypoxic-ischemic-encephalopathy 
(commonest cause), intracranial haemorrhage hypoglycaemia, 
hypocalcaemia, hypomagnesaemia, intracranial infections, developmental 
defects and drugs withdrawal
41 
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PATHOPHYSIOLOGY: 
During seizures there occurs abnormal synchronous electrical 
discharge (depolarization) in neuronal groups of brain. Depolarization is 
due to influx of sodium ions into neuronal cells, and repolarisation is due 
to potassium ions as they are pumped out of the cell. So the electrical 
potential is maintained across the cell membrane.                      
The electrical difference across the cell membrane is maintained 
mainly by the sodium potassium pump. The Na/K Pump requires ATP for 
its action across the membrane. This excessive depolarization of cell 
membrane is final common pathway of all cause of seizure. 
In Hypoxia ischemia, due to energy failure, lack of ATP the Na/K 
ATPase pump fails which leads to alteration in the electrical potential 
across the membrane leading to excessive depolarization and seizures. 
The mechanism of causation of seizures in metabolic abnormalities 
like hypoglycaemia, hypocalcemia and mainly hypomagnesemia are also 
by alteration in the electrical potential across the cell membrane by 
producing Na influx and depolarization. 
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REASONS FOR VULNERABILITY OF NEONATES FOR 
SEIZURES 
• In newborns the excitatory and inhibitory circuits are not well 
developed and the balance is shifted towards excitatory. The 
GABA which is primarily an inhibitory neurotransmitter in the 
adult brain acts like excitatory in newborns particularly in 
hippocampus area. 
• The activation of GABA A causes depolarization and activation 
of sodium channels and calcium channels. This depolarization is 
effective enough to release the block from NMDA channels 
42 
and cause influx of calcium into the immature neurons. And this 
step is dependent on magnesium. 
• Along with this , hippocampus and other neurocortical regions of 
neonatal  brain contains higher density of NMDA receptors, so it 
causes enhanced excitation and  prolongation of action potential 
in the NMDA; and sensitivity to glycine which is actually an 
excitatory neurotransmitter is also increased. So finally it reduces 
the ability of magnesium to block NMDA receptor activity
43-47
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• The development of anticonvulsant network takes long period 
after birth but the proconvulsant network is well developed and 
fully functional during birth. 
• The development and maturation of postsynaptic inhibitory 
system, like postsynaptic GABA-B, 5-hydroxytryptamine, and 
adenosine
48
 are delayed. 
• The Presynaptic inhibition is fully operational at birth and is 
mediated by adenosine, GABA-delta, and other receptors. So the 
inhibition in the neonatal brain predominantly will be relied upon 
the neurotransmitter release. 
• Due to the presence of large number of gap junctions in the 
developing brain there occurs amplification in the small 
imbalances in the neuronal activity leading to disorganisation of 
electrical activity and seizures 
49-52
.   
• And the refractory period in newborn are shorter and it causes 
hyperpolarisation during the postictal phase. 
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The final common pathway (Fig:3) for neonatal seizures is the 
changes in the energy metabolism. As soon as seizure activity is initiated 
there occur significant changes in the brain like  
1) Decline in ATP 
2) Substantial increase in the levels of adenosine diphosphate (ADP) 
3) Decline in the storage form of Adenosine Tri Phosphate- 
phosphocreatine 
4) Increase in glycolysis along with concomitant increase in 
pyruvate, lactate and significant decrease glucose concentration 
in the central nervous system (CNS) 
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Fig 3: Pathophysiology in neonatal seizures 
 
PATHOPHYSIOLOGICAL EVENTS IN HYPOXIC ISCHEMIC 
ENCEPALOPATHY:  
1. Accumulation of calcium 
Calcium is mainly an intracellular second messenger necessary for 
numerous cellular enzymatic reactions. NMDA receptor activation by 
hypoxic ischemic encephalopathy will cause a increase in influx of 
calcium into the cells. Calcium efflux across the plasma membrane is also 
affected by energy failure, which acts in opposite direction leading to 
  
22 
 
increased calcium inside the cells. And in addition Ca is also released into 
the cytoplasm from mitochondria. 
All these changes in calcium homeostasis will lead to increased 
intracellular calcium. So the enzymatic reactions are affected leading to 
activation of proteases, lipases, phospholipases and endonucleases. 
Finally there occurs formation of free radicals as by products. It ends in 
persistent epiletiform discharges on electroencephalogram(Fig:4). All 
these abnormalities during hypoxic ischemia lead to irreversible brain 
damage
53
.                 . 
2. Release of excitatory neurotransmitters: 
In developing human brain glutamate is a major excitatory amino 
acid 
54 
.The action of glutamate is mediated mainly by N-Methyl-D 
Aspartate (NMDA) receptor and also number of receptor subtypes. And 
these NMDA receptors are increased in areas of active development, like 
striatum or hippocampus.  
Within the NMDA receptor site, there are regions of antagonist 
activity, i.e., Magnesium ion, phencyclidine and also agonist activity, i.e., 
glutamate, glycine. Each of these sites has their own neuroprotective 
strategies.  
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This excessive glutamate release during hypoxic ischemic 
encephalopathy due to impairment in the uptake by presynaptic nerve 
endings will act via the NMDA receptor-mediated channel and causes 
intracellular entry of Calcium and leads to increased cytosolic calcium 
which causes irreversible brain damage. 
3. Formation of free radicals 
Due to hypoxic ischemic injury there is generation of free radicals 
like oxygen free radicals followed by nitric oxide and iron. All these free 
radicals act by causing injury to polyunsaturated fatty acid component 
55-
57
of cell membrane causing fragmentation and permanent cell death. 
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Fig: 4 EEG During seizure 
ETIOLOGY OF NEONATAL SEIZURES 
The cause of neonatal seizures  is multiple and diverse and has 
evolved significantly over the last two decades. In the past, cause was 
undetermined in approximately one-third of infants presenting with 
neonatal seizures. Recent neuroimaging technology has allowed for the 
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detection and definition of neuropathologic changes increasing the 
diagnostic acumen. 
In addition, improvements in neonatal intensive care have 
decreased mortality rates. Early onset seizures occur in HIE, ICH and 
metabolic causes. Late onset seizures occur with metabolic disease and 
drug withdrawal, but more frequently with intracranial infections
58
.  
The most common causes of seizures and time of onset are listed 
below. 
I. Age 1-4 days 
• Hypoxic ischaemic encephalopathy 
• Drug withdrawal, maternal drug use of narcotic/barbiturates 
• Drug toxicity, lidocaine, penicillin 
• Intraventricular haemorrhage 
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Acute metabolic disorders 
1. Hypocalcaemia – Perinatal asphyxia, small for gestational age, Sepsis 
                                 Maternal diabetes mellitus 
                                 Hyperthyroidism or hypoparathyroidism 
2. Hypoglycaemia – Perinatal insults, Prematurity 
                                 Small for gestational age 
                                 Maternal diabetes 
                                Hyperinsulinemic hypoglycaemia 
                                 Sepsis 
3. Hypomagnesemia 
4. Hyponatremia or hypernatremia 
                                   Iatrogenic/SIADH 
                                  Inborn errors of metabolism 
                                 Galactosemia 
                                  Hyperglycaemia 
               Urea cycle disorders 
                Pyridoxine deficiency (must be considered at any age) 
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II. Ages 4-14 days 
• Infection 
• Meningitis, encephalitis (enteroviral, herpes simplex) 
• Metabolic disorders 
• Hypocalcaemia 
• Hypoglycaemia 
• Drug withdrawal, maternal drug use narcotic/barbiturates 
• Benign neonatal convulsions, familial and non-familial 
• Kernicterus,  hyperbilirubinemia 
III. Ages 2-8 weeks 
• Infection 
• Herpes simplex or enteroviral encephalitis 
• Bacterial meningitis 
• Head injury – Subdural hematoma, child abuse 
• Inherited disorders of metabolism 
• Amino acidurias, urea cycle defects 
• Organic acidurias, neonatal adrenoleucodystrophy 
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• Malformations of cortical development 
• Lissencephaly 
• Focal cortical dysplasia 
• Tuberous sclerosis 
• Sturge Weber syndrome 
ETIOLOGY BASED ON PATHOPHYSIOLOGY 
1. Acute metabolic 
• Hypoglycaemia 
• Hypocalcaemia 
• Hypomagnesemia 
• Hyponatremia or hypernatremia 
• Withdrawal syndrome association with maternal drug use 
• Iatrogenic associated with inadvertent fetal administration of LA 
• Rare inborn errors of metabolism (including pyindoxine 
responsive) 
2. Cerebrovascular 
• Arterial and venous ischaemic stroke 
• Intracerebral hemorrhage 
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• Intraventricular hemorrhage 
• Subdural hemorrhage 
• Subarachnoid haemorrhage 
3. CNS Infection 
• Viral meningoencephalitis 
• Intrauterine (TORCH) infection 
4. Developmental 
• Multiple forms of cerebral dysgenesis 
5. HIE 
6. Genetic syndromic disorders(Rare) 
• Benign neonatal familial convulsion (Na and K channel mutations ) 
• Early myoclonic encephalopathy  
BIOCHEMICAL DISTURBANCES: 
Even with established etiology for neonatal seizures there is 
significant contribution to the seizure activity by the underlying 
biochemical abnormalities. So early recognition of associated 
biochemical abnormalities and appropriate treatment is essential for a 
better outcome. 
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The common metabolic abnormalities responsible for neonatal 
seizures are hypoglycaemia, hypocalcaemia and hypomagnesemia
.14
 
Hypoglycaemia:  
It is one of the commonest causes of neonatal seizures. 
Hypoglycaemia is more frequent in SGA neonates and infant of diabetic 
mother. The most critical determinant for the occurrence of neurological 
symptoms with neonatal hypoglycaemia
59-60
 is the duration of the 
hypoglycaemia and the time before treatment begun. It can present as 
seizures, jitteriness hypotonia, apnoea and stupor.  
Etiology and Risk factors 
1. Increased utilisation of glucose 
a. Diabetic mothers 
b. Large for gestational age infants 
c. Erythroblastosis 
d. Insulin producing tumors 
e. After exchange transfusion 
2. Decreased production/stores 
a. Prematurity 
b. IUGR 
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c. Inadequate caloric intake 
d. Delayed onset of feeding 
3. Increased utilisation and/or decreased production 
a. Perinatal stress 
b. Endocrine deficiency 
c. Defects in carbohydrate metabolism 
d. Defects in amino acid metabolism 
e. Polycythemia 
Hypocalcemia and hypomagnesemia will be discussed in detail.  
CALCIUM AND MAGNESIUM HOMEOSTASIS: 
Calcium forms the major inorganic constituent of bone along with 
phosphorus (P).  
Magnesium composition in the body makes it second common 
electrolyte and fourth common cation. 
.  The Ca and Mg composition in circulation is less than 1% of their 
corresponding total content distributed in the body. But the  disturbances 
in these minerals concentration cause a significant change in the 
physiology manifested as clinical symptoms and signs
61
. The body 
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composition is in such a way that at in all age groups calcium and 
magnesium occupies 99% and 60 % in the skeleton respectively.  
During adaptation from intra uterine to extra uterine life, the new 
born infant has to face certain challenges to maintain normal mineral 
homeostasis and to continue the rapid growth rate.  
The challenges faced are  
1. In intrauterine life the fetus starts to accrete calcium and 
magnesium at higher rates at the end of third trimester 
approximately calcium 120mg/kg/day and magnesium 
4mg/kg/day. This high rate of accretion is discontinued abruptly 
after birth. 
2. The homeostasis of calcium and magnesium mainly depends on 
the skeletal reservoir in adults which is a least reservoir in 
neonates
62-65
  
3. The establishment of appropriate nutrient intake needed for the 
mineral homeostasis  will take long delay in neonates especially 
in preterm and sick neonates  
4. Neonates are in need of higher requirement of calcium and 
magnesium for their skeletal growth in the first year because the 
approximate gain in the length of newborn in first year is 25 cm. 
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5. Hormone mediated mineral homeostasis is inadequate in neonates 
because of diminished end organ responsiveness during this 
period. 
  These challenges are faced by all neonates and a healthy new born 
responds and adapts physiologically but in some neonates with certain 
risk factors like infant of diabetic mothers, prematurity and with 
inheritable abnormalities in calcium channel receptors there occurs 
hypocalcemia and hypomagnesemia
66
 . 
Tissue Distribution 
In intrauterine life during the last trimester after 25 weeks of 
gestational age most of the calcium and magnesium are accrued (80%). 
The approximate daily accretion rate for calcium is 2.3-2.98 mmol Ca per 
kilogram of fetal body weight, and for magnesium 0.1-0.14 mmol Mg per 
kilogram fetal body weight. The total body calcium and magnesium of a 
newborn infant is approximately 28gms and 0.7 gms respectively
67-69
 
After birth, the distribution of calcium and magnesium in the body 
varies significantly. The calcium occupies almost 99% in the bones but 
magnesium is distributed variedly with 60% in bones and 20%(Fig:5) in 
the muscles and rest of the magnesium is distributed in the intracellular 
space of other tissues. 
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Fig 5: Distribution of magnesium 
Physiologic Control of calcium and magnesium: 
Hormones involved in calcium magnesium homeostasis are  
1. Parathormone PTH,  
2. 1,25 dihydroxyvitamin D (1,25(OH)2D)  
3. Calcitonin (CT),  
These hormones interact with each other and regulate the calcium 
and magnesium homeostasis in the body by acting on its target organs. 
The chief organs response for the calcium magnesium homeostasis 
are : kidney, intestine and bone. 
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The mineral homeostasis is not only dependent on the hormonal 
action but a significant proportion of homeostasis is achieved by the 
dietary intake of the minerals calcium, magnesium, phosphorus and also 
on sodium, glucose and proteins.  
The hormonal homeostatic mechanism for magnesium under 
normal physiological conditions is limited  
But for the proper calcium homeostasis magnesium plays a important 
role because of the following reasons  
• The production of parathormone hormone is regulated by 
magnesium and magnesium is essential for the target organ 
sensitivity to parathormone
70
  
• For the production of active vitamin D , Mg acts as a cofactor at 
the step involving 25-OH VitD 1α hydroxylase enzyme 
Parathyroid hormone 
The chief cells of parathyroid gland secrete the hormone and it is 
stored in the secretory granules. The hormone increases physiologically 
in coincidence with the fall in serum calcium levels in new born. The 
main action of PTH is to increase the serum calcium levels by its action 
on the target organs.
71-74
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Parathormone acts directly mainly on bone and kidney, and 
indirectly on intestine leading to increase in serum calcium levels(Fig:6) 
1. Action in bones – PTH causes of mobilisation of calcium from 
bones into blood by inducing the osteclasts mediated resorption 
in the bone 
2. Action in kidneys –PTH acts by increasing the renal distal tubular 
reabsorption of Ca 
3. Action in intestines – PTH increases the1,25(OH)2D production 
and secondary to this there occurs  increase in   intestinal Ca 
absorption. Action on the intestine is dependent on vitamin D   
Decrease in the serum levels of magnesium  stimulates PTH 
secretion,
75-76
 but  chronic hypomagnesemia usually causes inhibition of  
secretions of PTH.  
Mg is needed for adenylate cyclase, which gets inactivated during 
hypomagnesemia. This is the reason why there is increased resistance to 
action of PTH due  to hypomagnesemia. 
Calcitonin                
It is secreted primarily by the C cells of parathyroid gland and 
significant contribution from other tissues like mammary gland, brain 
pituitary and placenta. Its secretion initially increases in immediate 
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postnatal life and reaches a level 10 times higher than in the adults. Then 
calcitonin levels decrease steadily during infancy. 
The increase in serum calcium and serum magnesium 
concentration increases the serum calcitonin levels mediated through 
gastrin, glucagon and cholecystokinin. 
Hypocalcaemia, and vitamin D, suppresses the secretion of 
calcium. Calcitonin cats by increasing the renal excretion of phosphorus, 
Mg, and sodium. So it decreases the serum calcium concentration and it 
acts opposite to the action of PTH. 
Vitamin D 
Vitamin D is usually obtained from diet and also  synthesized 
endogenously. Dietary vitamin D is derived from plant sources in the 
form of ergocalciferal (vitamin D2) and from animal sources
77
 in the form 
of cholecalciferal (vitamin D3). 
- Vitamin D  is carried in the circulation by carrier protein and 
albumin 
- After its absorption into the liver it gets hydroxylated at the  
carbon 25 end to 25-OHD.  
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- Normally in body the most abundant form of  vitamin  D is 25-
OHD  
- Final step in the activation of vitamin occurs at the level of 
kidneys by its action on 25-OHD. It is hydroxylated further to 
1,25(OH)2D by 25-OHD-1αhydroxylase  and to 24,25-dihydroxy 
vitamin D by 25-OHD-24 hydroxylase.  
Non-classic control of mineral homeostasis 
Factors controlling these mineral homeostasis other than major 
hormones are insulin-like growth factor I, cortisol, estrogen, 
progesterone, TNF, transforming growth factor-β1, IL-1, IL-2,4&6, TNF-
α and interferon V. All these play a inter role in calcium and magnesium 
homeostasis. 
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Fig 6: Calcium Homeostasis 
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Hypocalcemia 
               Hypocalcemia in newborn is defined by total calcium serum 
concentration in term infants less than 2 mmol/L (8 mg/dL) and 1.75 
mmol/L (7 mg/dL) in preterm infants. And for measurement of   iCa 
hypocalcemia is defined as levels below 1.0 to 1.1 mmol/L (4.0 to 4.4 
mg/dL) depending on the particular ion-selective electrode used.
78
  
Hypocalcemia is classified into two types 
1. Early onset hypocalcemia- it occurs classically within first 72 
hours of life. Classically associated with prematurity, IUGR, 
Asphyxia and gestational diabetes.  
2. Late onset hypocalcaemia –which occurs after 72 hours of life 
mainly  during end of first week.  
Risk factors for hypocalcaemia 
Maternal 
• Insulin dependent diabetes 
• Hyperparathyroidism 
• Vit D or magnesium deficiency 
• Medications: Calcium antacid and anticonvulsant 
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Peripartum: Birth Asphyxia 
Infant 
• Intrinsic Prematurity 
• Malabsorption 
• Malignant infantile osteopetrosis 
• Parathyroid hormone: impaired synthesis, secretion, regulation or 
responsiveness. 
• Extrinsic Diet – Adequate calcium 
• Excess phosphorus 
• Enema – phosphate 
• Exchange transfusion with citrated blood                 
Hypomagnesemia 
The normal serum magnesium concentration is 0.7 – 1.15 mmol/l 
(1.7-2.8mg/dl). In body the majority distribution of magnesium is in the 
intracellular compartment that is around 90% , so hypomagnesemia 
indicates the decrease in total magnesium levels in the body, but plasma 
levels of magnesium can be normal. 
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Magnesium acts on the Na/K ATPase pump in the cell membrane 
and maintains the electrical potential gradient across the cell membrane 
and also maintains normal potassium concentration. So hypomagnesemia 
causes disturbances in this electrical gradient leading to excitability of 
cells. 
Regulation of magnesium levels are not influenced by hormones or 
enzymes directly (Fig: 7) 
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Fig 7: Magnesium homeostasis 
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Causes of neonatal hypomagnesemia 
1. Decreased tissue accretion 
• Infants of mothers with insulin-dependent diabetes or 
hyperparathyroidism 
• Small for gestational age infants 
• Chronic maternal magnesium deficiency 
2. Decreased absorption 
• Extensive small intestine resection 
• Specific intestinal magnesium malabsorption 
3. Increased loss 
• Intestinal fistula or diarrhoea 
• Hepatobiliary disorders 
4. Decreased renal tubular reabsorption 
• Primary – transient receptor potential channel protein 
mutation, renal tubulopathies with hypo or hypercalciuria 
• Secondary – extracellular fluid compartment expansion, 
osmotic diuresis, drugs (e.g.: loop diuretic, aminoglycoside, 
ibuprofen ovedose). 
  
45 
 
5. Others 
• Increased phosphate intake 
• Exchange transfusion with citrated blood 
6. Inherited disorders of renal magnesium handling 
• Primary hypomagnesemia with secondary hypocalcemia 
• Infantile isolated renal magnesium wasting (dominant) 
• Infantile isolated renal magnesium wasting (recessive) 
• Hypomagnesemia with hypercalciuria and nephrocalcinosis 
All these inheritable forms are due to mutation in the various 
proteins like transient receptor potential melastatin type 6(TRPM6), 
Cyclin M2(CNNM2), Claudin 
79-80
. 
CLINICAL FEATURES OF HYPOMAGNESEMIA: 
Early Symptoms  
- Anorexia,  
- Nausea,  
- Muscular weakness,  
- Cramps,  
- Lethargy and weight loss . 
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Late Symptoms  
- Hyperirritability,  
- Hyper excitability, 
- Muscle spasms,  
- Stridor  
- Tetany,  
- Convulsions.  
- Hypertension is common and pulmonary oedema can occur.  
- Supraventricular and ventricular tachyarrhythmia’s may also 
occur.  
TREATMENT OF HYPOMAGNESEMIA 
Hypomagnesemia if identified should not be treated alone with 
calcium or vitamin D because it will further aggravates the decrease in 
serum magnesium levels leading to worsening of symptoms.  
The treatment of hypomagnesemia is using magnesium salts. The 
dose of IV magnesium in the neonate is a 50% solution of magnesium 
sulfate, 0.05 to 0.1 mL/kg (0.1 to 0.2 mmol/kg, or 2.5 to 5.0 mg/kg of 
elemental magnesium). It has to be given either as slow intravenous 
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infusion or intramuscularly .based on the clinical response we need to 
repeat doses every 8 to 12 hours.  
MECHANISM OF ACTION OF MAGNESIUM SULPHATE :  
The anti epileptogenic property of magnesium sulphate is due to its 
following actions  
1. Effects of magnesium sulphate on blood 
2. Effect of magnesium sulphate on blood brain barrier  
3. Effect on NMDA channels in brain 
EFFECTS OF MAGNESIUM SULPHATE ON BLOOD VESSELS          
Magnesium acts as good vasodilator of uterine arteries, aorta ,and  
mesenteric arteries but on cerebral arteries the vasodilator effects are 
minimal.  
Decreased intracellular calcium, causes relaxation and 
vasodilatation. In endothelium, magnesium by unknown mechanism 
increase production of prostaglandin I2, which also decreases platelet 
aggregation. By increasing NO magnesium causes vasodilatation  
(Figure 8). 
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Fig 8: Effects of magnesium sulphate on blood vessels 
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EFFECT OF MAGNESIUM SULPHATE ON BLOOD BRAIN 
BARRIER  
Magnesium decreases the cerebral edema by its calcium 
antagonistic effect. Decreased cellular calcium leads to decreased 
endothelial cell contraction so preventing opening of tight junctions. 
1. This inhibits the paracellular transport of vascular contents, 
proteins, and ions. So the paracellular transport of contents 
causing edema is prevented by the action of magnesium. 
2. Magnesium also acts by down regulating the aquaporin 4 
(AQP4), situated at astrocytic end feet. By its down regulation it  
decreases cerebral edema. (through unknown mechanisms) 
(Figure 9). 
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Fig : 9 Effect of magnesium sulphate on blood brain barrier 
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ANTICONVULSANT ACTIVITY OF MAGNESIUM SULPHATE 
There is mass release  of excitotoxic neurotransmitters including 
glutamate during seizures. This excess glutamate activate NMDA 
receptor, causing  depolarization of numerous neurons. Magnesium by 
inhibiting NMDA receptors increase the seizure threshold, and limits the 
effect of glutamate. 
 
Fig 9: Anticonvulsant activity of magnesium sulphate 
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METHODOLOGY 
 
METHODS OF COLLECTION OF DATA 
              The present study is an observational study included 150 
neonates presenting with seizures admitted to NICU of Coimbatore 
medical college, hospital , Coimbatore  during the period of one year 
from July 2014 to July 2015. 
INCLUSION CRITERIA 
1. Neonatal seizures occurring in the first 4 weeks of life  
2. Neonates with neonatal seizures who were delivered at our 
hospital as well as outborn babies are included in the study. 
3. Neonates presenting with at least one of the following clinical 
type of seizures 
• Subtle seizures 
• Generalised tonic seizures 
• Multifocal clonic seizures 
• Focal seizures 
• Myoclonic seizures 
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EXCLUSION CRITERIA 
1. Jitteriness in neonates. 
2. Tetanic spasms in neonates. 
3. Outborn neonates treated with anticonvulsants were excluded 
from the study. 
4. Infant of diabetic mother  
5. Newborn with Congenital anomalies like Hydrocephalus, Arnold 
Chiari malformation, Dandy Walker malformation. 
Seizure: 
Seizure is defined as paroxysmal involuntary disturbance of brain 
function that may manifest as an impairment or loss of consciousness, 
abnormal motor activity, behavioral abnormality, sensory disturbance or 
autonomic dysfunction. 
Neonatal Seizures: 
Seizures occurring during first 4 weeks of life classified as 
neonatal seizures. 
These are classified according to classification given by Hill and 
Volpe in 1994.
1
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After selection of study group the predesigned proforma has been 
filled and the following histories are recorded 
Antenatal history 
- Age and parity of mother were noted.  
- History of whether regular ANC checkups were done or not was 
enquired  
- History of medical illness like diabetes, fever during pregnancy 
were asked.  
- History of obstetric complications like PIH, eclampsia, 
antepartum hemorrhage, oligo or polyhydromnios were taken  
- History  regarding medication enquired. 
Perinatal history 
- History of PROM, 
- Prolonged second stage of labour, 
- Meconium staining of liquor,  
- Place of delivery, type of delivery  
- Indication for forceps and caesarean section were enquired. 
- After delivery whether baby cried immediately or not,  
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- Any resuscitation done, were enquired. 
- If apgar score was done, it was noted  
- Medication given to the baby were recorded. 
Definition of birth asphyxia : The neonate was diagnosed with 
birth asphyxia if baby did not cry for more than three minutes after birth 
or documented apgar score was ≤ 3 at one minute and < 7 at 5 minutes of 
birth. 
Postnatal history 
- History of lethargy poor feeding,  
- History of  jaundice, 
- History of excessive cry, 
- History of  fever, vomiting  
- History of  seizures were taken. 
History of seizures 
Clinical details of each seizure is recorded in following pattern 
- Age of onset of seizures, 
- Type of seizures, 
- The duration of seizures, 
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- Number of seizures and 
- Consciousness during and between seizures were taken.  
The neonatal seizures were-classified according to Volpe’s 
classification into multifocal, clonic, focal tonic, tonic-and myoclonic. 
After appropriate history, detailed examination of neonate was 
done. 
Examination 
The vitals of the baby were recorded 
- Heart Rate, 
- Respiratory Rate,  
- Peripheral pulses, 
- Blood pressure, 
- Temperature, 
- Capillary filling time 
- General physical examination of neonate was done according to 
the proforma and any disparity in head size and shape, skin 
lesions were noted. 
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- Anthropometry of the neonate was recorded and gestational age 
was assessed according to New Ballard Scoring. 
- CNS examination was done as per the proforma. Other systems 
were also examined. 
Investigations 
The following investigations were done for neonatal seizures in all 
cases. 
1. Complete blood counts (hemoglobin, total count, differential count). 
Using sysmex Auto Analyser (Fig : 11) 
 
 
 
 
 
 
Fig 11: Sysmex auto analyzer 
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2. Sepsis screening:  
              Peripheral smear for band cells and toxic granules, 
              C-Reactive Protein  
              Blood culture if necessary. 
3. Blood glucose: 
  Random blood sugar was done urgently with glucostick and then 
confirmed by glucose oxidase method.  
Hypoglycaemia was diagnosed if RBS is <40 mg/dL. 
4. Serum electrolytes were done on emergency basis,  
- S. Ca, S. Na, S. Mg were done  
- Hypocalcaemia was defined when total serum calcium <7.0 
mg/dL, 
- Hypomagnesemia when serum Mg < 1.5 mg/dL, 
- Hyponatremia when S. Na <135 meq/L and  
- Serum calcium estimation by O-Cresolphthalein Complexone 
(OCPC) method. 
- Serum sodium and potassium estimation by I.S.E. Method (Ion 
Selective electrode) 
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- Blood Glucose estimation by Glucose oxidase method. 
- Serum magnesium by Arsenazo dye binding method 
In selected cases 
1. CSF Analysis: If septicemia or meningitis was suspected. LP was 
done and CSF  analysed for.  
• Cytology – Cell type, cell count 
• Biochemistry – Glucose, protein, Chloride. 
• Micro Biology – Culture, Gram Staining 
• Neonatal meningitis was diagnosed if CSF culture showed 
growth of organisms. 
 
Fig 12:CSF analysis 
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2. Chest X-ray was done in required cases 
3. USG examination was done in all babies with neonatal seizures to 
rule out ICH, hydrocephalus, congenital anomalies of brain and 
infarction. 
4. EEG Done whenever indicated to find out etiology 
5. CT-scan brain 
6. Other metabolic screening like serum ammonia was done if 
particular metabolic disease was suspected. 
All the patients were treated according to the protocol and 
diagnosis made. 
The results obtained were tabulated in the master chart and by 
applying the statistical analysis results were obtained.  
STATISTICAL ANALYSIS:  
Statistical analysis was performed using the Statistical software 
package [SPSS, version16.0 for windows] and consisted in computing the 
frequency count and percentages for qualitative variables, the mean and 
standard deviation for quantitative variables.  
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The comparison of the percentages and the means were performed 
using the chi-square test and the unpaired Student t-test p-value <0.05 
was considered significant. 
Sample Size Calculation  formula 
n   
t x p 1 
 p
m
 
     
Description: 
n = required sample size 
t = confidence level of 95% 
p = Expected Frequency of the Factor under Study  – 10% 
M = margin of error of 5% 
n   
1.962x 0.10 1 
 0.10
. 05
 
 
= 138 
 Contingency 
The sample is further increased by 10% to account for 
contingencies such as non-response or recording error. 
 n +10 % = 138 + 10% =152Samples 
                150 Samples (Round off) 
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OBSERVATION AND ANALYSIS 
 
1. PREVALANCE OF HYPOMAGNESEMIA IN THE STUDY 
GROUP  
Among the 150 study group hypomagnesemia is detected in 7 
babies which are around 4.6% of the group. 
 
 
Fig 13: Prevalence of hypomagnesemia in the study group 
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 2. DISTRIBUTION OF CAUSES OF SEIZURE IN THE STUDY 
    GROUP 
 
Among the 150 study group hypoxic
the most common cause of seizures 
Fig 14 : Distribution of causes of seizure
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Table 2 : Distribution of causes of seizures in the study group 
Causes n (%) 
Metabolic 34 22.7% 
Sepsis 22 14.7% 
HIE 58 38.7% 
Haemorrhage 8 5.3% 
Combined 26 17.3% 
IEM 2 1.3% 
Total 150 100% 
 
In our study the most common cause seizure is Hypoxic ischemic 
encephalopathy  with 38.7 % of total followed by Metabolic causes  with 
22.7%  of total. Sepsis/Meningitis causes 14.75% and intracranial bleed 
with IEM occupies the least common etiology. 
Significant proportion of group is occupied by combined cause 
which is around 17.3% mainly sepsis combined with electrolyte 
abnormalities. 
  
 3. DISTRIBUTION OF AGE AND GENDER IN THE STUDY 
GROUP 
Among the study group most of  the seizures occurs around the
group of < 5 days and
                     
Fig 15 : Distribution of age and gender in the study group
 Seizures in <5 
and 11-15 days age group occupies 10% and 9% respectively. 
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 male preponderance. 
days age group occupies 79%, 5-10 days age group 
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 4. DISTRIBUTION OF GENDER IN THE STUDY GROUP
 
In the selected group during the study period there is slight male 
preponderance in the occurrence 
and female child 41%
Fig 16 : Distribution of gender in the study group
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5. DISTRIBUTION OF AGE IN THE STUDY GROUP: 
 
 In the selected study group most common age of seizure 
occurrence is in less than 5 days group which occupies 79% of the total  
Table 3 : Distribution of age in the study group 
AGE 
GENDER 
TOTAL (%) 
MALE FEMALE 
< 5 Days 68 51 119 79% 
5 - 10 10 4 14 9% 
11 - 15 8 6 14 9% 
>15 Days 3 0 3 2% 
TOTAL 89 61 150   
 
 
The seizures occurring in >15 days age group is least which is around 2% 
in the study group implying that neonates are vulnerable to seizures in  
their early neonatal period. 
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6. MEAN AGE OF OCCURRENCE OF SEIZURES IN THESTUDY 
GROUP  
 The mean age of occurrence of seizure among males is 4.28 days 
and mean age for female is 3.54 days but it is statistically insignificant. 
Table 4: Mean age of occurrence of seizures in the study group 
Mean Age with Gender 
  
Mean 
SD 
95% CI for 
Mean 
Minimum Maximum Sig Gender [Days] Lower Upper 
MALE 4.28 4.801 3.27 5.29 1 24   
FEMALE 3.54 3.364 2.68 4.4 1 14 >0.05 
Total 3.98 4.278 3.29 4.67 1 24   
 
 And the mean age of occurrence of seizures in the total group is 
3.98 days, which in favours that the insults in earlier days are more severe 
and leads to long term sequale. 
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Fig 17 : Mean age of occurrence of seizures in the study group 
  
 7. DISTRIBUTION OF GESTATIONAL AGE AMONG THE 
STUDY GROUP 
Fig 18 : Distribution of gestational age among the study group
Table 5: Distribution of gestational age among the study group
GA 
PRE TERM 
TERM 
Total 
In the study group of 150 selected term babies occupies 
total and 22% of the total is preterm babies.
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 8. MEAN TIME OF ONSET FOR SEIZURES IN THE STUDY 
GROUP 
The mean time of onset of seizures in the study group is < 5days.
Fig 19 : Mean time of onset for seizures in the study group
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Table 6 : Mean time of onset for seizures in the study group 
Duration n (%) 
<5 118 79% 
6 - 15 29 19% 
16 - 25 3 2% 
Total 150 100% 
 
 
Table 7: Mean time of onset of seizure 
Mean Time of on set 
  Mean 
SD 
95% CI for Mean 
Minimum Maximum Duration   Lower Upper 
Time[Days] 4.11 4.368 3.41 4.82 1 25 
 
The mean time of onset for neonatal seizures in the study group 
selected is 4.11 days. 
  
 9. DISTRIBUTION OF METABOLIC ABNORMALITY AMONG 
THE STUDY GROUP
Though there is an established cause for seizures metabolic 
abnormalities are associated in 79 cases.
Fig 20 
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: Distribution of metabolic abnormality 
among the study group 
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Table 8: Distribution of metabolic abnormality  
among the study group 
CLINICAL VARIABLES n (%) 
Hypoglycaemia 46 30.7% 
Hypocalcemia 47 31.3% 
Hyponatremia 7 5% 
Hypomagnesemia 7 5% 
HC+HM 6 4% 
  
 So among the associated metabolic abnormality hypoglycaemia 
and hypocalcemia are the most common with 31% of each, followed by 
hyponatremia and hypomagnesemia occupying 7% each. 
  
 10. ASSOCIATION OF CAUSE OF SEIZURE WITH METABOLIC 
ABNORMALITY 
Fig 21 : Association of cause of seizure with metabolic abnormality
 Among the selected group HIE is most commonly associated with 
other biochemical abnormalities that is around 28 cases ou
associated with biochemical  abnormalities and hypocalcemia is the most 
common metabolic abnormality associated with HIE  
Followed by sepsis which is actually included in the combined 
group and in this group hypoglycaemia is the most common
Metabolic[n=33]
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Sepsis[n=22] HIE[n=58] Hemorage[n=8] Combined[n=26]
0% 12% 38%
9% 29% 13%
5% 5% 0%
0% 2% 0%
0% 0% 0%
 
 
t of 58  are 
. 
IEM[n=2]
69% 0%
35% 0%
12% 0%
4% 0%
4% 0%
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11. ASSOCIATION OF HYPOCALCEMIA WITH ESTABLISHED 
CAUSE OF SEIZURE 
 
Table 9 : Association of hypocalcemia with established  
cause of seizure 
Causes 
Hypocalcemia 
TOTAL (%) 
YES NO 
Metabolic 18 16 34 23% 
Sepsis 2 20 22 15% 
HIE 17 41 58 39% 
Haemorrhage 1 7 8 5% 
Combined 9 17 26 17% 
IEM 0 2 2 1% 
TOTAL 47 103 150   
     
 In our study 39 % of HIE is associated with hypocalcemia and 23% 
of metabolic cause has association to hypocalcemia followed by 
combined and sepsis cause which are associated with hypocalcemia 17% 
and 15% respectively. 
 
 Fig 22: Association of hypocalcemia with established cause of seizure
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12. ASSOCIATION OF HYPOMAGNESEMIA WITH 
ESTABLISHED CAUSE OF SEIZURE 
 
Table 10 : Association of hypomagnesemia with established  
cause of seizure 
Causes 
Hypomagnesemia 
TOTAL (%) 
YES NO 
Metabolic 5 29 34 23% 
Sepsis 0 22 22 15% 
HIE 1 57 58 39% 
Haemorrhage 0 8 8 5% 
Combined 1 25 26 17% 
IEM 0 2 2 1% 
TOTAL 7 143 150   
 
 In 7 cases of hypocalcemic - hypomagnesemia 5 cases are 
associated and stands as an isolated metabolic cause for seizure. 
1 out of 7 of hypocalcemic-hypomagnesemia associated with 
sepsis.  
1 out of 7 is an isolated hypomagnesemia.  
 Fig 23: Association of hypomagnesemia with established 
Hypomagnesemia is almost associated with hypocalcemia and 
other common association
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s are with sepsis and HIE. 
 
Sepsis HIE Hemorage Combined
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15% 40% 6% 17%
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 13. ASSOCIATION OF HYPOCALCEMIC
WITH ESTABLISHED CAUSE OF SEIZURE
Fig 24 : Association of HC+HM with established cause of seizure
 Among the 7 cases of hypomagnesemia 6 
hypocalcemia and its is mostly metabolic cause leading to seizure 
occupying around 8
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 14. MOST COMMON CAUSE OF SEIZURE IN INTRAMURAL 
AND EXTRAMURAL GROUP
Fig 25: Most common cause of seizure in intramural 
In the selected group of 150 the most common cause seizures in 
both intramural and extramural group is HIE which occupies 45% and 
32% respectively. This 
seizures among neonatal seizures. 
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and extramural group  
 
implies that HIE is the most common cause 
 
Sepsis HIE Hemorage Combined
17% 45% 9%
12% 32% 1%
 
 
 
IEM
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20% 3%
 15. ASSOCIATION OF CAUSE OF
GESTATIONAL AGE
Fig 26 : Association of cause of seizure with gestational age
 
 From the study it is inferred that metabolic abnormality are the 
most common cause of seizures in pre term group around 39%  followed 
by HIE of 33%  and in term
40%. 
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 group HIE is the most common cause around 
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DISCUSSION 
In our study 150 neonates were included who presented with 
seizures to us for the first time both intramural and extramural according 
to the inclusion and exclusion criteria, and investigations proceeded as 
discussed in methodology. 
Results of our primary objective: 
 In our study the prevalence of hypomagnesemia among 150 
selected neonates with seizures is 4.6%. 
Association of hypocaclcemia and hypomagnesemia 
• Among the total 7 in 150, all 6 cases were associated with 
hypocalemia 
• 85% of hypomagnesemia is associated with hypocalcemia 
• Among the 5 out of 6 in hypocalcemic- hypomagnesemia stands as 
an isolated metabolic cause of seizure. 
• And another 1 out of 6 in hypocalcemic-hypomagnesemia is 
associated with sepsis 
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• 1 out of 7 in hypomagnesemia is associated with HIE and it is an 
isolated hypomagnesemia without hypocalcemia. 
• So hypomagnesemia is almost associated with hypocalcemia and 
other common causes of association with hypomagnesemia are 
sepsis and HIE. 
 Among the 7 cases of hypomagnesemia 6 is associated with 
hypocalcemia. The rate of association of hypomagnesemia with 
hypocalcemia is 85%. 
Compaision of hypocalcemic-hypomagnesemia prevalence with other 
studies is shown in the following table: 
Table 11: Prevalence of Hypocalcemia and hypomagnesemia 
comparision of studies 
Studies 
Hypocalcemia Hypomagnesemia Combined 
N % N % N % 
Present study  18 52.9 7 20.5 6 17.6 
Kumar et al. 5 55.5 1 11.1 - - 
Arvind sood et al. 7 70 3 30 - - 
Ronengabreil et al. - - - - 5 29.4 
Ajay kumar et al. 9 42.8 - - 1 4.7 
Hatan tekgul et al. - - - - 1 33.3 
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 All the studies quoted above including our present study had a 
small sample size and the correlation results were statistically 
insignificant, so there is need for a research to find the association of 
hypocalcemia and hypomagnesemia with a large size of sample group 
and over a longer duration. 
Results derived from the study:  
From the observations made the following results were derived as 
secondary results in our study 
1. Distribution of cause of seizure in the study group: 
Among the selected study group the most common cause seizures 
are  Hypoxic ischemic encephalopathy  (38.7 %)  followed by Metabolic 
causes ( 22.7% )and Sepsis/Meningitis ( 14.75% ) and intracranial bleed / 
IEM occupies the least common etiology. 
Significant proportion of group is occupied by combined cause 
which is around 17.3% mainly sepsis combined with electrolyte 
abnormalities. 
In a study on neonatal seizures by Moayedi AR et al., etiology of 
neonatal seizures was HIE (36.4%) followed by infections (19.1%), 
metabolic disorders (7.3%), ICH (2.7%) and structural disorders (1.8%). 
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In 32.7% cases etiology was not identified. This study had findings 
similar to our study. 
Based on different studies conducted HIE is the most common 
cause of neonatal seizures followed by infections and metabolic causes. 
Seizures due to haemorrhage and inborn errors of metabolism are least. 
Comparison of cause of seizures with other studies: 
Table 12: Comparison of cause of seizures with other studies 
Study group 
HIE Infection Metabolic others 
N % N % N % N % 
Present study  58 38.7 22 14.7 34 22.7 36 24 
Ajay kumar et al. 40 44.4 7 7.7 21 23.3 22 14 
Moyaedi AR et al. 40 36.4 21 19.1 8 7.3 41 27 
Hatan Tekgul et al. 36 40.4 3 3.3 5 5-6 30 20 
Lakhra Mahaveer et al. 21 33 18 28 19 30 6 6 
Sandhan Ravneet et al. 34 42.5 17 21.2 20 25 9 9 
Brunqell Phillip et al. 26 49 1 2 1 2 25 16.6 
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2. Distribution of age /gender in the study group 
• Seizures in <5 days age group occupies 79%, 5-10 days age group 
and 11-15 days age group occupies 10% and 9% respectively.  
• In the selected group during the study period there is slight male 
preponderance in the occurrence of seizures with males occupying 
59% and female child 41%. 
Neonatal seizures have no sex predilection. However, in our study, 
male to female ratio was 1.43:1, similar with the study of neonatal 
seizures by Zakeri S et al. where male to female ratio was 1.3:1. The 
study of neonatal seizures by Hasan Tekgul et al. showed male to female 
ratio of 1.15:1. 
Most common age group for the seizure occurrence in our study 
group is <5 days age group in which seizure on first day is almost 40%. 
In a study of neonatal seizures by Ronen Gabriel et al. onset of seizures 
on first day of life was 36%, 64% had onset of seizures within first 48 
hours and 83% within first week of life, which is similar to our study. 
Onset of seizures within first 5 days constitutes the majority of cases, 
more so within first 48 hours of life.  
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3. Mean age of occurrence of seizure:  
 The mean age of occurrence of seizure among males is 4.28 days 
and mean age for female is 3.54 days but it is statistically insignificant. 
And the mean age of occurrence of seizures in the total group is 3.98 
days, which in favours that the insults in earlier days are more severe and 
leads to long term sequale. 
4. Comparison of Gestational age with seizures 
In the study group of 150 selected, term babies occupies 78% of 
the total and 22% of the total is preterm babies. 
Similar observations was seen in study by Moayedi AR et al. 
where term AGA babies were 83.6% and preterm were 12.7% and post 
term 3.6%. Study by Ravneet Sandhu et al. where term AGA babies were 
81.2% followed by preterm babies in 18.8% which is similar to our study. 
5. Biochemical abnormality in study group 
Though there is an established cause for seizures metabolic 
abnormalities are associated in 79 cases out of 116 (68%) and,  34 cases 
had isolated metabolic abnormality as cause for seizure. 
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Among the associated metabolic abnormality hypoglycaemia and 
hypocalcemia are the most common with 31% of each, followed by 
hyponatremia and hypomagnesemia occupying 7% each. 
Among the selected group HIE is most commonly associated with 
other biochemical abnormalities that is around 28 cases out of 58  are 
associated with biochemical  abnormalities and hypocalcemia is the most 
common metabolic abnormality associated with HIE   
Followed by sepsis which is actually included in the combined 
group and in this group hypoglycaemia is the most common association. 
The most common disease to be associatedwith metabolic 
bnormality is HIE.  The most common metabolic abnormality to be 
associated is hypocalcemia and hypoglycemia .39 % of HIE is associated 
with hypocalcemia and 23% of metabolic cause has association to 
hypocalcemia followed by combined and sepsis group which are 
associated with hypocalcemia 17% and 15% respectively. 
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6. Cause of seizure in intramural and extramural group: 
In the selected group of 150 the most common cause seizures in 
both intramural and extramural group is HIE which occupies 45% and 
32% respectively  which implies that HIE is the most common cause 
seizures among neonatal seizures. 
7. Cause of seizure in association with gestational age: 
From the study it is inferred that metabolic abnormality are the 
most common cause of seizures in pre term group around 39%  followed 
by HIE of 33%  and in term group HIE is the most common cause around 
40%. 
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SUMMARY 
 
• A group of 150 neonates with seizures were studied  
• Total of 7 cases had hypomagnesemia 
• Among the total 7 hypomagnesemia cases in 150, all 6 cases were 
associated with hypocalemia 
• 85% of hypomagnesemia is associated with hypocalcemia 
• Among the 5 out of 6 in hypocalcemic- hypomagnesemia stands 
as an isolated metabolic cause of seizure. 
• And another 1 out of 6 in hypocalcemic-hypomagnesemia is 
associated with sepsis 
• 1 out of 7 in total hypomagnesemia is associated with HIE and it 
is an isolated hypomagnesemia without hypocalcemia. 
• The prevalence of hypomagnesemia in study group is 4.6% 
• The prevalence of hypocalcemic-hypomagnesemia is 4% 
• The prevalence of isolated hypomagnesemia is 0.6% 
• The association of hypomagnesemia with hypocalcemia is 
statistically significant  
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• Most common cause of seizure is Hypoxic ischemic 
encephalopathy  (38.7 %)   
• Metabolic causes of seizure ( 22.7% ) Sepsis/Meningitis as cause 
of seizure ( 14.75% ) and intracranial bleed / IEM occupies the 
least common etiology. 
• Significant proportion of group is occupied by combined cause 
which is around 17.3% mainly sepsis combined with electrolyte 
abnormalities. 
• In the selected group during the study period there is slight male 
preponderance in the occurrence of seizures with males 
occupying 59% and female child 41%. 
• In our study, male to female ratio was 1.43:1 
• The mean age of occurrence of seizure among males is 4.28 days 
and mean age for female is 3.54 days but it is statistically 
insignificant. 
• In the study group of 150 selected term babies occupies 78% of 
the total and 22% of the total is preterm babies. 
• The most common disease to be associated with metabolic 
abnormality is HIE 48.2%   
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• The most common metabolic abnormality to be in associatio with 
other causes is hypocalcemia and hypoglycemia each 31%. 
• Most common etiology in both intramural and extramural group 
is HIE which occupies 45% and 32% respectively. 
• Most common etiology in pre term group is metabolic 
abnormality 39% followed by HIE of 33% and in term group HIE 
cause around 40%. 
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CONCLUSION 
 
• Hypomagnesemia as isolated abnormality for cause of seizure, or 
as associated abnormality in underlying etiology is rare. But 83% 
of hypomagnesemia is associated with hypocalcemia implying 
the interrelation in pathophysiology. So in documented 
hypocalcemia there is a need to estimate the levels of magnesium 
to find the associated hypomagnesemia because treatment of 
hypomagnesemia is definitive with magnesium salts.  
• Biochemical abnormalities are treatable and investigations for 
biochemical abnormality should be the first line of investigations, 
before starting anticonvulsants. 
• However further studies are required with large number of cases 
to establish the rate of association of hypomagnesemia with 
hypocalcemia. 
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ANNEXURE 1 
PROFORMA 
 
NAME: IP NO: 
AGE(in hours/days): DOB/TOB: 
SEX: MCH/FCH MOD :  LN/LSCS/FORCEPS 
GESTATIONAL AGE: INDICATION:  
TERM/PRETERM (wks)  
SGA/AGA/LGA/IUGR 
BIRTH WEIGHT: 
ADMISSION WT: 
RESUSCITATION DETAILS: 
Tactlie 
stimulation 
Bag and Mask Intubation 
BMV- chest 
compressions 
 
APGAR SCORE : 1 “     5”    NOT KNOWN 
HC:                            CC:                             LENGTH: 
MATERNAL H/O: 
H/O ANY MATERNAL ILLNESS DURING PREGNANCY AND 
MEDICATIONS GIVEN: 
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S.NO DISEASE TREATMENT/SPECIFICATIONS 
1 PIH / IMMINENT 
ECLAMPSIA 
Anti hypertensives / Mgso4 
2 GDM Insulin / diet 
3 APH Placenta previa / abruption 
4 PROM / PPROM <12 hrs / >12 hrs 
5 ANEMIA On IFA tab/ Injection/ transfusion 
6 MECONIUM STAINED Yes/ no 
 
TIME OF OCCURENCE OF FIRST EPISODE OF SEIZURES: 
HOURS OF LIFE:                                                   DAYS: 
 
CLINICAL EXAMINATION: 
CVS: 
RS: 
P/A: 
CNS: 
 
Vitals : 
Temp:  HR:  RR:  Spo2: 
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INVESTIGATIONS: 
CBG VALUE AT THE TIME OF ADMISSION: 
CBC:  TC: 
           DC: 
           HB: 
           PLATLET: 
CRP: 
BLOOD C/S: 
CSF STUDY: 
CELL COUNT: 
BIOCHEM: PROTEIN 
SUGAR 
GLOBULIN 
CSF C/S 
SERUM SODIUM: 
SERUM POTASSIUM: 
SERUM CALCIUM : 
SERUM MAGNESIUM: 
USG CRANIUM IF DONE: 
 
Anticonvulsants needed to control seizures  
Dextrose alone   
Dextrose + calcium   
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Phenobarbitone 1
st
 2
nd
 3
rd
   
Phenobarbitone + phenytoin   
Midazolam infusion  
 
 
IF PRESENT : 
Hypomagnesemia   
Hypocalcemia  
Hypomagnesemia+Hypocalcemia  
Hypoglycemia  
Hyponatremeia   
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CONSENT FORM 
 Your child ………………… is being asked to be a participant is 
the research study titled "STUDY TO EVALUATE THE 
PREVALENCE HYPOMAGNESEMIA IN NEONATAL 
CONVULSIONS" in CMCH,  Coimbatore, conducted by 
Dr.Vikneswari.K, Post graduate student, Department of Paediatrics, 
Coimbatore Medical College Hospital your Child is eligible after looking 
on the inclusion criteria.  You can able any question you may have, 
before agreeing to participate. 
RESEARCH BEING DONE: To determine the prevalence of 
hypomagnesemia in neonatal convulsions. 
PURPOSE OF RESEARCH: To find association of seizure with 
hypomagnesemia. 
PROCEDURE: Investigated as per protocol 
DECLINE FROM PARTICIPATION: You have the option to decline 
from participation in the study existing protocol for your condition. 
PRIVACY AND CONFIDENTIALITY: Privacy of the individuals will 
be respected and any information about your child provided by you 
during the study will be kept strictly confidential. 
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AUTHORIZATION TO PUBLISH RESULTS: Results of the study 
may be published for scientific purpose and / or presented to scientific 
groups; however your child will not be identified. 
STATEMENT OF CONSENT: 
I volunteer and consent my child to participate in the study. I have read 
the consent or it has been read to me. The study has been fully explained 
to me, and I may ask questions at any time. 
 
 
…………………………     ……………………… 
Signature / left thumb impression of parent  Date: 
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xg;g[jy; gotk;; [ ; ;; [ ; ;; [ ; ; 
 
bgah;     : 
taJ     : 
ghypdk;    : 
Kfthp    : 
 
muR nfhit kUj;Jtf; fy;Yhhpapy; bghJ kUj;Jt Jiwapy; 
gl;l nkw;gog;g[ gapYk; khztp bry;tp fp. tpf;nd!;thp ; ; ;; ; ;; ; ; mth;fs; 
nkw;bfhs;Sk; "gr;rpsk; FHe;ijfspd; typg;g[ nehapy; bkf;dP!pak; ; ; ; ; ; [ ; ; ;; ; ; ; ; [ ; ; ;; ; ; ; ; [ ; ; ;
Fiwghl;od; fzf;fst[; ; ; [; ; ; [; ; ; [" gw;wpa Ma;tpy; bra;Kiw kw;Wk; midj;J 
tpsf;f';fisa[k; nfl;Lf; bfhz;L vdJ re;njf';fis bjhpt[gLj;jpf; 
bfhz;nld; vd;gij bjhptpj;Jf; bfhs;fpnwd;. 
 
ehd; ,e;j Ma;tpy; KG rk;kjj;JlDk;/ Ra rpe;jida[lDk; 
fye;J bfhs;s rk;kjpf;fpnwd;. 
 
,e;j Ma;tpy; vd;idg; gw;wpa midj;J tpgu';fs; ghJfhf;fg; 
gLtJld; ,jd; Kot[fs; Ma;tpjHpy; btspaplg;gLtjpy; Ml;nrgiz 
,y;iy vd;gij bjhptpj;Jf; bfhs;fpnwd;. ve;j neuj;jpYk; ,e;j 
Ma;tpy; ,Ue;J ehd; tpyfpf; bfhs;s vdf;F chpik cz;L 
vd;gija[k; mwpntd;. 
 
,lk; 
njjp  
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KEY TO MASTER CHART: 
Sex M=Male F=Female  
IM/EM IM=intramural EM=Extramural 
GA GA- gestational age  
PT-Preterm , T-Term 
B.Wt 
Ad.Wt 
Birth weight  
Admission weight  
Resuscitation 
details  
N=Nil T=Tactile stimulation  
Step 1,2,3 is one,two,three cycle of Bag and mask 
ventilation respectively 
Step 4intubation 
TOS Time of onset of seizure  
Investigations  TC-Total count WNL-within normal limits, s-sepsis 
 Hb- haemoglobin, N-normal L- Low  
CRP-C reactive protein,  
P-positive N-Negative  
C/S – culture and sensitivity, 
G-growth NG-no growth  
CSF- cerebro spinal fluid analysis,  
N-Normal M-Meningitis 
Sr.Ca- serum calcium,Sr.Na-serum Sodium, 
Sr.Mg – Serum Magnesium, Sr.Sugar- serum sugar 
N=normal L=Low  
( as defined in methodology)  
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Cause of seizure  1.Metabolic 
2.Sepsis 
3.Hie 
4.Hemorraghe 
5.Combined  
6.IEM 
Drugs used to 
control seizure  
1-dextrose alone 
2-dextrose+calcium 
3-Dextrose+calcium+Phenobarbitone 
4.Dextrose+calcium+Phenobarbitone+Phenytoin 
5.Requried midazolam 
HG Hypoglycemia 
HC Hypocalcemia 
HN Hyponatremia 
HM  Hypomagnesemia 
Y/N Y-yes N-No 
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MASTER CHART  
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IEM=6 
S
t
e
p
 
1
,
2
,
3
,
4
,
5
 
HG HC HN HM HC+HM 
TC Hb 
M,F 
 
<
1
k
g
=
1
 
 
1
-
2
.
5
=
2
 
>
2
.
5
=
3
 
<
1
k
g
=
1
 
 
1
-
2
.
5
=
2
 
>
2
.
5
=
3
 
<
 
3
=
1
,
 
 
 
 
 
 
 
3
-
6
=
2
,
 
 
 
 
 
>
7
=
3
 
W
N
l
/
 
S
e
p
s
i
s
 
N/L P/N 
N
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N
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N
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M
e
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i
t
i
s
=
M
 
N/L N/L N/L N/L Y/N Y/N Y/N Y/N Y/N 
1 B/o Devi 2 m IM T 3 3 N 3 2 N L N NG . N N N L 4 4 Y N N N N 
2 B/o Deepa 11 F EM T 3 3 N 3 11 N N N NG N N N N N IEM 2 N N N N N 
3 B/o Rajathi 2 M IM T 3 3 N 3 2 S N P NG N N N N N 2 4 N N N N N 
4 B/o Anantha lk 6 F EM T 3 3 N 3 6 S L P G N L N N L 5 1 Y Y N N N 
5 B/o Nandhini 4 M EM PT 2 2 N 3 4 N N . . . N N N L 1 1 Y N N N N 
6 B/o Saranya 3 M IM T 3 3 N 3 3 N N . . . L N L N 1 3 N Y N Y Y 
7 B/o kasthuri 1 M IM T 2 2 T 2 1 N N . . . N L N N 3 3 Y N N N N 
8 B/o Lakshmi 1 F IM T 3 3 4 1 1 N N . . . N N N N 3 5 N N N N N 
9 B/o Thilagavathi 24 M EM T 2 2 N 3 24 S N N G M L N N N 5 2 N Y N N N 
10 B/o Suseela 4 M IM PT 2 2 N 3 4 S N N NG M N N N N 2 3 N N N N N 
11 B/o Revathy 13 M EM PT 2 2 N 3 14 S N P G N N N N L 5 3 Y N N N N 
12 B/o s.revathy 1 M IM T 3 3 2 1 1 N N . . . N N N N 3 4 N N N N N 
13 B/o Amirtham 1 M IM T 3 3 2 1 1 N N . . . L N N N 3 4 N Y N N N 
14 B/o Anandhi 5 F IM T 3 3 N 3 5 S N N NG N N N N N 2 4 N N N N N 
15 B/o Gokila 11 F EM T 3 2 N 3 11 S N P NG M N N N N 2 4 N N N N N 
16 B/o Amudha 6 M EM T 3 3 N 3 6 S N P G M L N N L 5 1 Y Y N N N 
17 B/o Rani 3 M IM T 3 3 N 3 3 S N P NG M N N N N 2 3 N N N N N 
18 B/o Thangamani 4 F IM T 3 3 N 3 4 N L N NG . N N N N 4 4 N N N N N 
19 B/o Stella 3 M IM T 3 3 N 3 3 N L N NG . N N N N 4 5 N N N N N 
20 B/o Kaousalya 1 F IM PT 2 2 T 2 1 N N . . . N L N N 3 3 Y N N N N 
21 B/o Yasodha 3 M IM T 3 3 N 3 3 N N . . . L N L N 1 4 N Y N Y Y 
22 B/o pavithra 10 M EM PT 3 3 N 3 10 N N N . . N N N L 1 1 Y N N N N 
23 B/o Poongodi 3 M IM T 3 3 N 3 3 N N . . . L N N N 1 2 N Y N N N 
24 B/o Shanthi 2 F EM T 3 3 N 3 2 N N . . . L N N N 1 2 N Y N N N 
25 B/o Rajeswari 1 M IM T 3 3 T 2 1 N N . . . L N N N 3 3 N Y N N N 
26 B/o Jayanthi 1 M EM T 3 3 1 2 2 N N . . . N N N N 3 3 N N N N N 
27 B/o Jayanthini 1 M EM T 3 3 1 2 1 N N . . . N N N N 3 3 N N N N N 
28 B/o Bhuvanes 4 M EM T 3 3 N 3 4 N N . . . L N N N 1 2 N Y N N N 
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N/L N/L N/L N/L Y/N Y/N Y/N Y/N Y/N 
29 B/o farzana 1 F IM T 3 3 3 1 1 N N . . . N N N N 3 4 N N N N N 
30 B/o Muthu lk 1 F EM T 3 3 3 1 1 N N . . . N N N N 3 4 N N N N N 
31 B/o Radhika 3 M EM T 3 3 N 3 5 S N P G N N N N N 2 1 N N N N N 
32 B/o Sangeetha 12 F EM T 2 2 N 3 12 S N P G N N N N N 2 1 N N N N N 
33 B/o Gowthami 8 M EM PT 2 2 N 3 9 S L P NG M N N N N 2 3 N N N N N 
34 B/o Niramala 5 F IM T 2 2 N 3 7 S N P NG N N N N L 5 2 Y N N N N 
35 B/o Mary 8 M EM PT 2 2 N 3 8 S N P NG M N N N N 2 4 N N N N N 
36 B/o eswari 2 M IM T 3 3 N 3 2 S N P NG N N N N L 5 1 N N N N N 
37 B/o Samsath 1 F EM T 3 3 2 1 1 N N . . . N N N N 3 4 N N N N N 
38 B/o Poornima 12 M EM PT 3 3 N 3 12 N N N . . N N N L 1 1 Y N N N N 
39 B/o Mallika 4 M IM T 3 3 N 3 4 N N . . . N N N L 1 1 Y N N N N 
40 B/o Kaveri 2 F IM T 3 3 N 3 2 S N P NG N N N N L 5 1 Y N N N N 
41 B/o jeeva 4 F EM T 3 3 N 3 4 S N P G N L N N L 5 2 Y Y N N N 
42 B/o Sridevi 4 F IM PT 3 3 N 3 4 N N . . . L N L N 1 4 N Y N Y Y 
43 B/0 Divya 6 M EM T 3 3 N 3 7 S N P G N N N N L 5 2 Y N N N N 
44 B/o Ramani 1 F IM T 3 3 T 2 1 N N . . . L N N N 3 4 N Y N N N 
45 B/o Kanmani 10 F EM PT 2 2 N 3 10 S N P G M N N N L 5 2 Y N N N N 
46 B/o sasmitha 1 F IM PT 2 2 1 2 1 N N . . . N N Y N 3 4 N N N Y N 
47 B/o Praba 1 M IM T 3 3 3 1 1 N N . . . N N N N 3 5 N N N N N 
48 B/o Poornima 3 F IM T 3 3 N 3 3 S L P NG N N N N N 2 4 N N N N N 
49 B/o Vasanthi 1 F EM PT 2 2 2 1 2 N N . . . N N N N 3 4 N N N N N 
50 B/O thilaga  11 F EM T 3 2 N 3 11 N N N . . N N N L N 2 Y N N N N 
51 B/o savithri 2 M EM T 3 3 N 3 2 N N . . . N N N L 1 1 Y N N N N 
52 B/o Ruckmani 23 M EM T 3 2 N 3 25 S L P G M L N L N 5 3 N Y N Y Y 
53 B/O Ranjitha 1 F IM T 3 3 T 2 1 N N . . . L N N L 3 3 Y Y N N N 
54 B/o vellaiamal 2 M IM T 3 3 N 3 2 N N N NG . L N N N 4 4 N Y N N N 
55 B/o sajeena 1 M EM T 3 3 1 2 2 N N . . . N N N N 3 4 N N N N N 
56 B/O thulasimani 1 F IM T 3 3 3 1 1 N N . . . L N N N 3 3 N Y N N N 
57 B/o Ilaya 3 M EM PT 3 3 N 3 3 N N . . . L N N N 1 2 N Y N N N 
58 B/o Yogapriya 1 F EM T 3 3 1 2 2 N N . . . L N N N 3 3 N Y N N N 
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N/L N/L N/L N/L Y/N Y/N Y/N Y/N Y/N 
59 B/o arulselvi 4 M EM T 3 3 N 3 4 N L N NG . N N N L 4 4 Y N N N N 
60 B/o Gomathi 1 F IM T 3 3 1 2 1 N N . . . N N N N 3 4 N N N N N 
61 B/oLavanya 4 F EM PT 3 3 N 3 4 N N N . . N N N L 1 1 Y N N N N 
62 B/o Gurupriya 14 F EM T 3 3 N 3 14 N N N NG N N N N N IEM 4 N N N N N 
63 B/o Raji 2 F EM T 3 3 N 3 2 N N . . . N N N L 1 1 Y N N N N 
64 B/o Amala 4 M IM T 3 3 N 3 4 N N . . . L N N N 1 2 N Y N N N 
65 B/o Thangam 5 M IM T 3 3 N 3 5 S N P G N N L N N 5 3 N N Y N N 
66 B/o Hema 1 M EM T 3 3 3 1 1 . N . . . N N N N 3 4 N N N N N 
67 B/o Indira 3 M EM T 3 3 N 3 3 N N . . . N N N L 1 1 Y N N N N 
68 B/o Lalitha  2 M IM T 3 3 N 3 2 N L N NG . N N N N 4 5 N N N N N 
69 B/o Kalyani 2 F IM T 3 3 N 3 2 S N P NG N N N N L 5 1 Y N N N N 
70 B/o Agalya 1 M EM T 3 3 3 1 1 N N . . . N N N N 3 4 N N N N N 
71 B/o Saroja 1 M IM T 3 3 4 1 1 N N . . . N N N N 3 5 N N N N N 
72 B/o Asmitha 1 M EM T 3 3 T 2 1 N N . . . L N N L 3 3 Y Y N N N 
73 B/o Amirtham 5 F EM T 2 2 N 3 5 S N P G N L N N N 2 3 N Y N N N 
74 B/o Preethi 2 M IM T 3 3 N 3 2 N L N NG . N N N L 4 4 Y N N N N 
75 B/o Usha  5 F IM T 3 3 N 3 5 S N P NG N N L N N 5 3 N N Y N N 
76 B/O preetha 1 F EM T 2 2 1 2 2 N N . . . L N N N 3 3 N Y N N N 
77 B/oGomathi 2 M IM T 3 3 N 3 2 S N P G M L N N L 5 2 Y Y N N N 
78 B/o ranjani 1 M EM T 3 3 T 2 1 N N . . . N N N N 3 3 N N N N N 
79 B/o Anjali 4 M EM PT 3 3 N 3 4 N N N . . L N N L 1 2 Y Y N N N 
80 B/o Chellam 2 F IM T 3 3 N 3 2 N L N NG . N N N N 4 4 N N N N N 
81 B/o Suganthi 3 F IM T 3 3 N 3 3 S N P NG N N N N L 5 2 Y N N N N 
82 B/o Gandhimati 1 M IM T 2 2 2 1 1 N N . . . N N N N 3 4 N N N N N 
83 B/O Manju 2 F IM T 3 3 N 3 2 S N P NG N N N N N 2 4 N N N N N 
84 B/o Parimala 4 M IM T 2 2 N 3 4 S N P NG M N L N N 2 4 N N Y N N 
85 B/o Surya 2 M IM T 3 3 N 3 2 S N P NG N L N N N 2 4 N Y N N N 
86 B/o Banu 2 F IM T 2 2 N 3 2 S N P NG M N N N N 2 4 N N N N N 
87 B/o Suba 1 M EM T 3 3 1 2 1 N N . . . N N N N 3 3 N N N N N 
88 B/o Rupa 1 M IM T 3 3 2 1 1 N N . . . N N N N 3 3 N N N N N 
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N/L N/L N/L N/L Y/N Y/N Y/N Y/N Y/N 
89 B/o Ragavi 4 F IM T 2 2 N 3 4 S N N G M N L N L 5 1 Y N Y N N 
90 B/o sathyapriya 6 M IM T 3 3 N 3 6 N N . . . N N N L 1 1 Y N N N N 
91 B/o Meenakshi 14 M EM T 3 2 N 3 14 S N P NG N L N N N 1 2 N Y N N N 
92 B/o Sangeetha 1 M IM T 2 2 T 2 1 N N . . . N N N N 3 4 N N N N N 
93 B/o Sasmi 7 F EM PT 2 2 N 3 7 S L P NG M N N N L 5 2 Y N N N N 
94 B/o Rupa 1 M IM PT 2 2 2 1 1 N N . . . N N N N 3 5 N N N N N 
95 B/o Kanmani 7 M EM T 2 2 N 3 8 S L P NG M N N N L 5 2 Y N N N N 
96 B/o anbu 6 M IM PT 3 3 N 3 6 N N N . . N N N L 1 1 Y N N N N 
97 B/o puspha 2 M EM PT 2 2 N 3 2 N N . . . L N N L 1 2 Y Y N N N 
98 B/o rani 5 F IM PT 2 2 N 3 5 S L P NG M N N N L 5 3 Y N N N N 
99 B/o Dharshini 1 F EM T 3 3 3 1 1 N N . . . N N N N 3 4 N N N N N 
100 B/o Ruckmani 7 M EM T 3 3 N 3 7 S L N NG M L N N N 5 3 N Y N N N 
101 B/o Anitha 1 F IM T 3 3 T 2 1 N N . . . N N N L 3 3 Y Y N N N 
102 B/o Beulah 11 F EM T 3 3 N 3 11 S N P G M N N N N 2 4 N N N N N 
103 B/o Banu 1 F IM T 3 3 2 1 1 N N . . . N N N N 3 4 N N N N N 
104 B/o Chitra 1 M IM PT 2 2 1 2 1 N N . . . N N N N 3 3 N N N N N 
105 B/o Kannagi 3 M EM T 3 3 N 3 3 N N . . . N N N L 1 1 Y N N N N 
106 B/o Sumathi 1 M IM T 3 3 1 2 1 N N . . . N N N N 3 4 N N N N N 
107 B/o Rasiya 1 M EM T 3 3 3 1 1 N N . . . N N N N 3 5 N N N N N 
108 B/o Sakthhi 1 F IM T 3 3 T 2 1 N N . . . L N N N 3 3 N Y N N N 
109 B/o Divya 7 F IM T 3 3 N 3 7 N N N . . N N N L 1 1 Y N N N N 
110 B/o Jothi 1 M EM T 3 3 3 1 1 N N . . . L N N N 3 4 N Y N N N 
111 B/o Yasmin 11 M EM PT 2 2 N 3 12 S N P NG M N N N N 2 4 N N N N N 
112 B/o Saradha 1 M IM T 3 3 T 2 1 N N . . . N N N N 3 4 N N N N N 
113 B/o hajira 1 M EM T 3 3 1 2 2 N N . . . N N N N 3 3 N N N N N 
114 B/o Susi 8 M EM T 3 3 N 3 8 S L P NG M N N N N 2 4 N N N N N 
115 B/o Akani 1 M EM PT 2 2 4 1 1 N N . . . N L N N 3 5 N N Y N N 
116 B/o Samta 3 M EM T 3 3 N 3 3 N N . . . L N N N 1 2 N Y N N N 
117 B/o Anitha 12 M EM PT 2 2 N 3 12 S N P NG N N N N L 1 1 Y N N N N 
118 B/o Poornima 1 F IM T 3 3 3 1 1 N N . . . N N N N 3 4 N N N N N 
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Investigations Cause of seizure drug inference 
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N/L N/L N/L N/L Y/N Y/N Y/N Y/N Y/N 
119 B/o Sumi 20 M EM T 3 3 N 3 20 S L P G M L N N N 5 3 N Y N N N 
120 B/o Yasmin 3 M EM PT 3 3 N 3 3 N N . . . L N N N 1 2 N Y N N N 
121 B/o Saleema 1 M EM T 3 3 T 2 1 N N . . . L N N N 3 3 N Y N N N 
122 B/o Baby 1 M EM PT 2 2 4 1 1 N N . . . N L N N 3 5 N N Y N N 
123 B/o Chitra 1 M IM T 3 3 2 1 1 N N . . . L N N N 3 4 N Y N N N 
124 B/o Sameena 4 M IM T 3 3 N 3 4 N L P G M N N N N 2 4 N N N N N 
125 B/o Mano 1 F IM T 3 3 T 2 1 N N . . . L N N N 3 4 N Y N N N 
126 B/o Karunya 1 F IM PT 2 2 1 2 1 N N . . . N N N N 3 3 N N N N N 
127 B/o Kiruba 5 M IM T 3 3 N 3 5 N N . . . L N L N 1 3 N Y N Y Y 
128 B/o Geetha 1 F EM PT 2 2 2 1 2 N N . . . N N N N 3 4 N N N N N 
129 B/o eswari 4 M IM T 3 3 N 3 4 S N P NG M N N N L 5 1 Y N N N N 
130 B/o Vani 3 F EM T 3 3 N 3 3 N N . . . L N L N 1 2 N Y N Y Y 
131 B/o Divya 3 M EM T 3 3 N 3 3 N N . . . L N N N 1 2 N Y N N N 
132 B/o Kirthika 11 M EM T 3 3 N 3 11 S N N G N N N N L 5 4 Y N N N N 
133 B/o Kokila 1 M IM T 3 3 2 1 1 N N . . . L N N N 3 4 N Y N N N 
134 B/o Jaya 5 F EM PT 3 3 N 3 5 N N N . . L N N N 1 2 N Y N N N 
135 B/o chandra 1 M EM T 3 3 T 2 1 N N . . . L N N L 3 3 Y Y N N N 
136 B/o Gayathri 3 M EM T 3 3 N 3 3 N N . . . N N N L 1 2 Y N N N N 
137 B/o Raseena 11 M EM T 2 2 N 3 12 S N N G N L N N N 5 2 N Y N N N 
138 B/o Mariammal 1 F IM T 3 3 2 1 1 N N . . . L N N N 3 4 N Y N N N 
139 B/o aiyama 1 F IM T 3 3 4 1 1 N N . . . N N N N 3 5 N N N N N 
140 B/o Anju 1 F EM T 3 3 1 2 2 N N . . . N L N N 3 4 Y N N N N 
141 B/o Vennila 14 M EM T 3 2 N 3 14 S N P G M N N N L 5 2 Y N N N N 
142 B/o Haseena 4 F IM T 3 3 N 3 4 S L P G M N N N N 2 4 N N N N N 
143 B/o Gowri 3 M EM T 3 3 N 3 3 N N . . . N N N L 1 1 Y N N N N 
144 B/o Gowthami 1 F EM PT 2 2 T 2 1 N N . . . N N N N 3 3 N N N N N 
145 B/o Anju 5 F IM T 3 3 N 3 5 S N P NG N N N N N 2 3 N N N N N 
146 B/o Geetha 1 M IM T 3 3 3 1 1 N N . . . N N N N 3 4 N N N N N 
147 B/o Yogam 1 F IM T 3 3 4 1 1 N N . . . N N N N 3 5 N N N N N 
148 B/o Ammu 3 F EM PT 3 3 N 3 3 N N . . . L N N N 1 3 N Y N N N 
149 B/o rani 5 F IM PT 2 2 N 3 5 S N P NG N N N N N 2 3 N N N N N 
150 B/o Devi 1 M IM PT 2 2 4 1 1 N N . . . N L N N 3 5 N N Y N N 
 
